Home » FDA Approves Biotronik’s Tiny Quadripolar Cardiac Resynchronization Therapy Pacemaker
FDA Approves Biotronik’s Tiny Quadripolar Cardiac Resynchronization Therapy Pacemaker
Biotronik secured FDA approval for its Edora HF-T QP MR conditional quadripolar cardiac resynchronization therapy pacemaker (CRT-P).
The device allows physicians to tell the implant an MRI exam is coming up, so the device can to automatically engage its MRI safety mode during a scan.
The device has a total volume of only 15 cc, making it the smallest MR-conditional CRT-P on the U.S. market.
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May